Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes


Creative Commons License

Watson A. M. D. , Olukman M. , KOULİS C., TU Y., SAMİJONO D., Yuen D., ...Daha Fazla

DIABETOLOGIA, cilt.56, ss.1155-1165, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 56 Konu: 5
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s00125-013-2837-9
  • Dergi Adı: DIABETOLOGIA
  • Sayfa Sayıları: ss.1155-1165

Özet

Aims/hypothesis The small, highly conserved vasoactive peptide urotensin II (UII) is upregulated in atherosclerosis. However, its effects in diabetes-associated atherosclerosis have not been assessed.